Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. - Wikidata - wikimedia - TriplyDB

Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.

Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.

http://www.wikidata.org/entity/Q36431827

about

Insulin in central nervous system: more than just a peripheral hormone Nitric oxide and peroxynitrite in health and disease Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications Brain changes in diabetes mellitus patients with gastrointestinal symptoms Lutein, Zeaxanthin, and meso-Zeaxanthin in the Clinical Management of Eye Disease Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity Metabolic syndrome: an important risk factor for Parkinson's disease Poly(ADP-ribose) polymerase inhibition reveals a potential mechanism to promote neuroprotection and treat neuropathic pain Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications Mitochondrial stress and the pathogenesis of diabetic neuropathy Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US.Schwann cell interactions with axons and microvessels in diabetic neuropathy.Diabetic neuropathy: mechanisms to management Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production.Persimmon Leaves (Diospyros kaki) Extract Protects Optic Nerve Crush-Induced Retinal Degeneration.Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets.Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes.Peroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advances Mechanisms of disease: the oxidative stress theory of diabetic neuropathy Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model.Update on the management of diabetic polyneuropathies.Loss of survival factors and activation of inflammatory cascades in brain sympathetic centers in type 1 diabetic mice.Phenotypic changes in diabetic neuropathy induced by a high-fat diet in diabetic C57BL/6 mice.Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion.Taurine reduces nitrosative stress and nitric oxide synthase expression in high glucose-exposed human Schwann cells.Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress.Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats.Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.

P2860

Q21296648-17498C57-665D-4783-8B7F-90ED0EB490E8 Q24645400-A4FA6AD6-7328-4708-BB2A-4E7AA7ACA417 Q26752842-60CEDEE4-FB4D-4429-8742-42E5F030C938 Q26769999-83014841-E9B2-4B31-AC4D-CDD59BD7C602 Q26773085-05ABB758-7EFE-4B2E-BB2E-E60C12E66362 Q26773988-79CC903F-393C-4E5D-B2C5-39125B04B32A Q27023711-3DC6D6DD-09E0-4F94-8C8D-11EB783E2D8C Q28073384-F0CA1380-3227-4323-85DE-1D0D79B4851D Q28076120-DD485864-5437-49FA-A84A-1EE4C6BC7173 Q28382887-D784574B-3660-449D-8AE5-0B3EBD3CE45F Q28385506-2165A0C0-6CAE-43B6-87EC-4F5417A8452F Q28388746-07237D60-F666-4FE4-85F3-FD4C46BC026A Q30236003-BA2C0E68-A192-4ED2-8312-40BFB9B0BC2C Q30238727-673DCB37-5565-4C1D-83DF-7E239A459BAC Q33554384-CD1BFF3C-E5A7-45E5-A01F-5D173B1A7C44 Q33569693-135615EF-9EF8-47DE-9BA7-2E23E4418542 Q33571909-B771BF6B-9348-44AB-A158-E3E292A46936 Q33582677-1F283DFD-EA20-4CCA-957C-8A88BF8E4033 Q33614346-3CAA699B-B5DA-4291-964C-E67E0B07AD70 Q33813553-7B9B65DA-138D-450A-8A5E-1ED9E5426CE7 Q33874485-0D47F83D-D3D1-474C-97D2-7EE2A2F27A91 Q34313633-DD95001A-A572-40D3-AA85-46B8B3FBC775 Q34314724-3AF7F9E7-2052-45A0-A6AE-0B96F8EEDAB7 Q34553052-042D5ABA-262C-44D7-BE7D-43C673BDAEA7 Q34603026-3B374E04-E169-48AE-969C-C1A5CD917A1C Q34653233-C7E9BB14-4456-4BB5-87C1-8D8F05DD0BE5 Q34667363-53BD1B33-EF58-4543-9763-A079EBDAC666 Q34851871-E3838B57-EDE9-4697-A074-4D55068D2FFD Q34983617-F17E9F72-6808-45D3-9A42-6644020A66B9 Q35178801-0A45451C-1E0C-456A-9764-84D4C6135950 Q35436829-4F341575-B07B-4485-BD3D-43464A8D2CE9 Q35579658-FA35873C-8EF4-4649-BF65-E955407B4B13 Q35648004-EB7DBA81-04CD-44E0-ABDF-FC134BA7FFEE Q35713992-84D7509F-C7B1-4918-AC94-B8C1A729D33F Q35784340-45F70DF1-6E08-4557-B178-8B2A29403A6F Q35854702-8282356E-049D-4F16-978E-153D0DCE3303 Q36109233-1BFFA8C0-B77E-4B82-AF3D-BF8279586093 Q36293649-4012609E-34B6-4FFF-ACEA-441DC4EFF704 Q36398989-1EEF4C67-C710-4D44-B0ED-4096D1AC8FB3 Q36426801-4766B44D-4D25-42CB-905F-0A27B778C3B3

P2860

Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.

http://www.wikidata.org/entity/Q36431827

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Oxidative-nitrosative stress a ...... hy: the relation is revisited.

@ast

Oxidative-nitrosative stress a ...... hy: the relation is revisited.

@en

type

label

Oxidative-nitrosative stress a ...... hy: the relation is revisited.

@ast

Oxidative-nitrosative stress a ...... hy: the relation is revisited.

@en

prefLabel

Oxidative-nitrosative stress a ...... hy: the relation is revisited.

@ast

Oxidative-nitrosative stress a ...... hy: the relation is revisited.

@en

P1433

Q36431827-C7ACEF51-9714-42FE-A21C-9817D44A73C7

P1476

Q36431827-3ABF37E0-7150-488F-889E-EA8D4C396767

P2093

Q36431827-2D1B528F-DEF3-4D94-B706-A9F3EE78C772

Q36431827-639E18F5-B757-41D0-BE70-D84ADAC7E15D

Q36431827-97BCD92A-A24D-461E-A793-AB8877904F25

Q36431827-CB2DAFF7-7DC9-4236-B873-BBA98CB8ABBB

P2860

Q36431827-07C23DAD-95E7-478A-8F9A-952A611BBD75

Q36431827-0B91562D-78A3-48A5-8544-D51482C55989

Q36431827-15C128C5-58C5-4123-B00A-13CB83EC0729

Q36431827-1ABE4DFF-D946-4D2E-A673-5FCDEA3B3FF6

Q36431827-1F1AD6C8-2138-4B62-8860-4885567FD27D

Q36431827-2A9765D0-DC2C-4CAD-9196-E93F3F46E643

Q36431827-34E9DEA9-F3C6-4210-87CA-706016F8F68D

Q36431827-4DB98138-A7E2-4EC2-9D95-4B1E095CBA2A

Q36431827-50F9E7C6-110C-4A40-899A-CEDB5A0604EA

Q36431827-524A6425-C0DB-4B41-AD66-EF4D113ACA4B

P304

Q36431827-028A9A49-F064-4914-B10C-3CD20FAFD692

P31

Q36431827-415DC498-F077-481A-B2D6-C294018DFC70

P356

Q36431827-54DA6116-11F3-4037-9AF5-B2468EE748B8

P407

Q36431827-2DD97ADC-C35C-4145-ABAD-9378134988E4

P433

Q36431827-7F445EFB-7775-48E4-B6FE-D6610660547B

P478

Q36431827-39C549A3-FA32-4253-B199-023865B5A907

P50

Q36431827-4036E384-ECA8-4903-BC7B-2EE5124617E7

Q36431827-B8C83B23-B2F0-4D4B-A58F-861F4A8328B6

Q36431827-EE3BB1A8-491B-4F9D-9CA9-E1F1FA728C12

P577

Q36431827-0B154A77-3C4B-471D-9A00-BA0A65518F2F

P5875

Q36431827-75B87F71-D979-405F-8DE8-386C0E9FF322

P698

Q36431827-A4F52C72-11F7-436C-BFC0-09228E50B1DB

P932

Q36431827-BAEBDC91-5E70-4527-AE0C-1353591E8D63

P356

DIABETES.54.12.3435

P1433

P1476

Oxidative-nitrosative stress a ...... hy: the relation is revisited.

@en

P2093

Irina G Obrosova

http://www.w3.org/2001/XMLSchema#string

Martin J Stevens

http://www.w3.org/2001/XMLSchema#string

Olga Ilnytska

http://www.w3.org/2001/XMLSchema#string

Zhong Q Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia.

Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase.

Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation.

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options.

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.

DNA-binding properties of poly(ADP-ribose) polymerase: a target for anticancer therapy.

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.

Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.

Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.

P304

3435-3441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIABETES.54.12.3435

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7463182

http://www.w3.org/2001/XMLSchema#string

P698

16306359

http://www.w3.org/2001/XMLSchema#string

P932

2228259

http://www.w3.org/2001/XMLSchema#string